Peter van Mourik

226 Appendices de Jonge HR, Beekman JM, van der Ent CK. Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis. Cell Rep. February 2019. Other publications Geurts MH, de Poel E, Amatngalim GD, Oka R, Meijers FM, Kruisselbrink E,  van Mourik P , Berkers G, de Winter-de Groot KM, Michel S, Muilwijk D, Aalbers BL, Mullenders J, Boj SF, Suen SWF, Brunsveld JE, Janssens HM, Mall MA, Graeber SY, van Boxtel R, van der Ent CK, Beekman JM, Clevers H. Cell Stem Cell. April 2020. Berkers G, van der Meer R, van Mourik P , Vonk AM, Kruisselbrink E, Suen SW, Heijerman HG, Majoor CJ, Koppelman GH, Roukema J, Janssens HM, de Rijke YB, Kemper EM, Beekman JM, van der Ent CK, de Jonge HR. Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation. J Cyst Fibros. June 2020. Berger P,  van Mourik P , Toorop RJ, van Reekum F, van Zuilen A. Outcome of the living kidney donor. Nephrol Dial Transplant. August 2012